Cashu
Divergent Analyst Views on Exelixis Amidst Biopharmaceutical Competition and Market Challenges
7 days ago
Stocks
Health Care
exel
Exelixis
NASDAQ: EXEL
+0.46 (+1.11%)
41.75
USD
At close at Mar 11, 20:35 UTC
Latest Exelixis News
benzinga.com
Forecasting The Future: 11 Analyst Projections For Exelixis
10 days ago
prnewswire.com
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
16 days ago
benzinga.com
Earnings Scheduled For November 4, 2025
4 months ago
benzinga.com
What's Driving the Market Sentiment Around Exelixis Inc?
4 months ago
benzinga.com
Merck's New Cancer Therapy Combo Shows Significant Edge Over Rivals In Renal Cancer
4 months ago
benzinga.com
What to Expect from Biomarin Pharmaceutical's Earnings
5 months ago
cnbc.com
Stocks making the biggest moves midday: Apple, Cleveland-Cliffs, Oracle, KLA, Tempus AI and more
5 months ago
zerohedge.com
Futures Rise As Trade, Credit Fears Fade Ahead Of Earnings Deluge
5 months ago
benzinga.com
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session
5 months ago
benzinga.com
17 Analysts Have This To Say About Exelixis
6 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.